Announcements Trials
Browse Landscape

Phase

Phase 2 82Phase 1 32Phase 3 31Phase 1/2 26Phase 2/3 6Phase NA 5Phase EARLY_PHASE1 3Phase 4 1

Status

Unknown 3Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 3NIH 1INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 5

Conditions

Rectal Neoplasms 10Colorectal Neoplasms 8Stomach Neoplasms 6Pancreatic Neoplasms 5Esophageal Neoplasms 5Colonic Neoplasms 5Breast Neoplasms 5Keratosis, Actinic 4Nasopharyngeal Neoplasms 3Nasopharyngeal Carcinoma 3Carcinoma, Hepatocellular 3Recurrence 2Neoplasms 2Head and Neck Neoplasms 2Carcinoma, Squamous Cell 2Uterine Cervical Neoplasms 1Pseudomyxoma Peritonei 1Peritoneal Neoplasms 1Pathologic Complete Response 1Neoplasm Metastasis 1Neoadjuvant Therapy 1Locally Advanced Rectal Cancer 1Keratosis 1Hyperthermia 1Gastrointestinal Neoplasms 1Esophageal Squamous Cell Carcinoma 1Appendiceal Neoplasms 1Anus Neoplasms 1Advanced Gastric Cancer Adenocarcinoma of Esophagogastric Junction 1Advanced Colorectal Cancer 1

Interventions

Standard of Care 18Gemcitabine 18Radiosurgery 14Drug Therapy 13Blood Specimen Collection 13Endoscopic Ultrasound-Guided Fine Needle Aspiration 11Exercise 10Pancreaticoduodenectomy 9Practice Guidelines as Topic 8Methods 8Magnetic Resonance Spectroscopy 8Biopsy, Fine-Needle 8Capecitabine 7Early Intervention, Educational 6Biopsy 6Surveys and Questionnaires 5Stents 5Specimen Handling 5Resistance Training 5Radiofrequency Ablation 5Psychiatric Rehabilitation 5Oxaliplatin 5Fluorouracil 5Cholangiopancreatography, Endoscopic Retrograde 5130-nm albumin-bound paclitaxel 5Secretin 4Radiotherapy 4Irinotecan 4Heavy Ion Radiotherapy 4Electroporation 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase NA × Pancreatic Neoplasms × Fluorouracil × Clear all
NCT07325214 2026-01-12

Chemotherapy With or Without IMD10 (Focused Ultrasound) in the Treatment of Borderline Resectable or Locally Advanced Pancreatic Cancer

IMGT Co., Ltd.

Phase NA Not yet recruiting
136 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT01771146 2017-01-31

Neoadjuvant FOLFIRINOX Regimen in Patients With Non-metastatic Pancrease Cancer

Baylor Research Institute

Phase NA Unknown
30 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT01411072 2014-10-03

Biomarker Directed Adjuvant Chemotherapy for Resected Pancreas Cancer

AHS Cancer Control Alberta

Phase NA Unknown
20 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT01760694 2014-08-15

Multi-Modality Therapy for Untreated Patients With Resectable or Marginally Resectable Pancreatic Cancer

Southwestern Regional Medical Center

Phase NA Terminated
6 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT00079365 2013-12-04

Fluorouracil, External-Beam Radiation Therapy, and Gemcitabine With or Without Brachytherapy Using Phosphorus P32 in Treating Patients With Locally or Regionally Advanced Unresectable Adenocarcinoma of the Pancreas

National Cancer Institute (NCI)

Phase NA Unknown
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡